Nukkleus (DFNS) Stock Price, News & Analysis

Company Overview

Nukkleus, Inc. (NASDAQ: DFNS) is a technology company focused on developing and acquiring businesses in the defense, security and advanced technology sectors. Its activities are centered on solutions designed to support military, government and commercial customers, with an emphasis on emerging technologies and strategic innovation.

The company has historically operated in financial technology. Through its former businesses, Nukkleus provided infrastructure and technology supporting online foreign-exchange and contracts-for-difference trading, including trading platforms, liquidity services, risk-management tools and related back-office functions for international clients.

Nukkleus has since been repositioning its business toward defense-related opportunities and has pursued investments and acquisitions intended to expand its capabilities in this area. The company’s operations and portfolio may continue to evolve as it implements this strategic transition.

Key Stats

• Today's Range: $7.63 to $7.90
• 50-Day Range: $3.90 to $84.98
• 52-Week Range: $3.70 to $1,948.75
• Volume: 157,461 shs
• Average Volume: 515,522 shs
• Market Capitalization: $12.93 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

Nukkleus Stock Analysis - MarketRank™

Nukkleus scored higher than 19% of companies evaluated by MarketBeat, and ranked 609th out of 671 stocks in the industrials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Nukkleus has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Nukkleus has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Nukkleus are expected to grow in the coming year, from ($3.90) to ($3.21) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Nukkleus is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nukkleus is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

23.06% of the float of Nukkleus has been sold short.

Short Interest Ratio / Days to Cover

Nukkleus has a short interest ratio ("days to cover") of 0.51, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nukkleus has recently increased by 13.13%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nukkleus does not currently pay a dividend.

Dividend Growth

Nukkleus does not have a long track record of dividend growth.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: N/A

News Sentiment

Nukkleus has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Industrials companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Nukkleus this week, compared to 3 articles on an average week.

Search Interest

Only 5 people have searched for DFNS on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Nukkleus to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

Company Ownership

• Score: 0.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nukkleus insiders have not sold or bought any company stock.

Percentage Held by Insiders

11.14% of the stock of Nukkleus is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

12.47% of the stock of Nukkleus is held by institutions.

Company Calendar

• Last Earnings: 8/19/2026
• Today: 9/26/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Industrials
• Industry: Aerospace & Defense
• Sub-Industry: Aerospace & Defense
• Current Symbol: NASDAQ:DFNS
• Previous Symbol: NASDAQ:NUKK
• CIK: 1787518
• Web: www.nukk.com
• Phone: 212-791-4663
• Fax: N/A
• Employees: 12
• Year Founded: 2013

Profitability

• EPS (Trailing Twelve Months): ($397.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $78.55 million
• Net Margins: N/A
• Pretax Margin: -1,854.62%
• Return on Equity: -190.60%
• Return on Assets: -26.92%

Debt

• Debt-to-Equity Ratio: 0.07
• Current Ratio: 0.14
• Quick Ratio: 0.11

Sales & Book Value

• Annual Sales: $5.91 million
• Price / Sales: 2.19
• Cash Flow: $389.50 per share
• Price / Cash Flow: 0.02
• Book Value: ($90.93) per share
• Price / Book: -0.09

Miscellaneous

• Outstanding Shares: 1,660,000
• Free Float: 1,479,000
• Market Cap: $12.93 million
• Optionable: N/A
• Beta: -5.88